{"changes":[{"companyHref":"/c/aurontx-com","date":"2026-09-25","documentUrl":null,"domain":"aurontx.com","fact":"latest round","name":"Auron Therapeutics, Inc.","new":{"amountUsd":13400000,"date":"2024-12-18","lead":null,"type":null},"old":{"amountUsd":13400000,"date":"2024-12-18","lead":null,"type":"seed"},"publisher":"sec-edgar","reason":null,"retrievedAt":"2026-05-05","slug":"aurontx-com","status":"attributed","url":"https://whoraisedwhat.com/c/aurontx-com"}],"country":"US","description":"AI-driven AURIGIN drug-discovery platform with a lead candidate, AUTX-703, targeting cell-state plasticity. Develops therapies for AML, small-cell lung cancer, and neuroendocrine prostate cancer. Combines machine learning with biological insight to design small molecules in oncology and inflammation.","domain":"aurontx.com","employees":null,"founded":null,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"bio","investors":[],"lat":42.330044,"lng":-71.194862,"location":"Newton, MA","name":"Auron Therapeutics, Inc.","rounds":[{"amountQuarantined":false,"amountUsd":13400000,"currency":"USD","date":"2024-12-18","investors":[],"leadInvestor":null,"source":{"fact":"round","publisher":"sec-edgar","retrievedAt":"2026-05-05","status":"attributed","url":null},"status":"attributed","type":null,"url":null}],"slug":"aurontx-com","sources":[{"fact":"round","publisher":"sec-edgar","retrievedAt":"2026-05-05","status":"attributed","url":null},{"fact":"existence","publisher":"aurontx.com","retrievedAt":"2026-05-05","status":"self-reported","url":"https://aurontx.com"},{"fact":"description","publisher":"aurontx.com","retrievedAt":"2026-05-05","status":"self-reported","url":"https://aurontx.com"}],"stage":null,"techStack":["Cloudflare","Google Font API","Google Hosted Libraries","Google Tag Manager","jquery 3.5.1"],"totalRaisedUsd":13400000,"updatedAt":"2026-05-05"}